OVERVIEW

Hexarelin (2 mg x 10) is a synthetic growth hormone–releasing peptide (GHRP) known for its strong ability to stimulate the release of growth hormone (GH) from the pituitary gland. It works by mimicking ghrelin, a naturally occurring hormone that binds to growth hormone secretagogue receptors. Due to its potency, Hexarelin has been studied for its potential effects on muscle growth, recovery, fat metabolism, and overall anabolic support. Some research has also explored its possible cardiovascular benefits, including protective effects on heart tissue under certain experimental conditions. Because it can significantly elevate growth hormone and prolactin levels, its use requires careful consideration and appropriate medical oversight.

CJC-1295 no DAC (2 mg x 10) is a modified form of growth hormone–releasing hormone (GHRH) designed to stimulate the natural pulsatile release of growth hormone. The “no DAC” version has a shorter half-life compared to the DAC (Drug Affinity Complex) version, meaning it acts more similarly to the body’s natural GHRH rhythm when administered in timed intervals. It is often discussed in performance and anti-aging contexts for its potential to support lean muscle mass, fat loss, sleep quality, and recovery. When referenced together, Hexarelin and CJC-1295 no DAC are typically described as complementary peptides that stimulate growth hormone release through different but synergistic pathways.